Literature DB >> 24823883

Prevalence of deficient retro-aortic rim and its effects on outcomes in device closure of atrial septal defects.

Michael L O'Byrne1, Andrew C Glatz, Sherzana Sunderji, Aswathi E Mathew, David J Goldberg, Yoav Dori, Jonathan J Rome, Matthew J Gillespie.   

Abstract

Deficient retro-aortic rim is of concern as a risk factor for aortic erosion after device closure of atrial septal defects (ASD). However, its prevalence and contribution to technical failure and adverse outcomes have not been delineated. A single-center retrospective cohort study of children and adults undergoing cardiac catheterization for device occlusion of ASD from 1 January 1999 to 1 April 2012 was performed. Risk factors for technical failure and early adverse outcome were assessed using multivariate logistic regression. During the study period, 445 consecutive subjects with a median age of 5.9 years (range, 0.8-80 years) underwent catheterization. Of the subjects with reviewable echocardiograms, 60 % had deficient retro-aortic rim. No attempt at device closure was made for 3.6 % of the subjects. Of the remaining 429 subjects, 96 % underwent successful device occlusion. Major early adverse events occurred in 1.2 % (95 % confidence interval 0.4-2.7 %) of the cases, all of them either device embolization or malposition. Deficient retro-aortic rim was not a risk factor for composite outcome of technical failure or early major adverse event. No deaths, late reinterventions, or erosion events occurred during 2,395 total person-years (median, 5.8 years) of follow-up evaluation. Deficient retro-aortic rim was associated with increased risk of device impingement on the aorta, but no association was seen between device impingement or deficient retro-aortic rim and the development of new/progressive aortic insufficiency. Deficient retro-aortic rim is highly prevalent but did not increase the risk of adverse outcomes. Its contribution to the risk of aortic erosion could not be addressed by this study.

Entities:  

Mesh:

Year:  2014        PMID: 24823883      PMCID: PMC4167195          DOI: 10.1007/s00246-014-0914-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  22 in total

1.  Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patent foramen ovale.

Authors:  S P Schoen; A Boscheri; S A Lange; M U Braun; J Fuhrmann; U Kappert; R H Strasser
Journal:  Heart       Date:  2007-12-10       Impact factor: 5.994

Review 2.  Major complications associated with transcatheter atrial septal occluder implantation: a review of the medical literature and the manufacturer and user facility device experience (MAUDE) database.

Authors:  Jeffrey W Delaney; Jennifer S Li; John F Rhodes
Journal:  Congenit Heart Dis       Date:  2007 Jul-Aug       Impact factor: 2.007

3.  Continued controversy regarding adverse events after Amplatzer septal device closure: mass hysteria or tip of the iceberg?

Authors:  Daniel J DiBardino; John E Mayer
Journal:  J Thorac Cardiovasc Surg       Date:  2011-07       Impact factor: 5.209

Review 4.  Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence.

Authors:  Gianfranco Butera; Giuseppe Biondi-Zoccai; Giuseppe Sangiorgi; Raul Abella; Alessandro Giamberti; Claudio Bussadori; Imad Sheiban; Zackhia Saliba; Tiberio Santoro; Gabriele Pelissero; Mario Carminati; Alessandro Frigiola
Journal:  EuroIntervention       Date:  2011-07       Impact factor: 6.534

Review 5.  Analysis of factors related to successful transcatheter closure of secundum atrial septal defects using the HELEX septal occluder.

Authors:  Larry A Latson; Thomas K Jones; Joth Jacobson; Evan Zahn; John F Rhodes
Journal:  Am Heart J       Date:  2006-05       Impact factor: 4.749

6.  Long-term (5- to 20-year) outcomes after transcatheter or surgical treatment of hemodynamically significant isolated secundum atrial septal defect.

Authors:  Shelby Kutty; Anas Abu Hazeem; Kimberly Brown; Christopher J Danford; Sarah E Worley; Jeffrey W Delaney; David A Danford; Larry A Latson
Journal:  Am J Cardiol       Date:  2012-02-13       Impact factor: 2.778

7.  Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk.

Authors:  Zahid Amin; Ziyad M Hijazi; John L Bass; John P Cheatham; William E Hellenbrand; Charles S Kleinman
Journal:  Catheter Cardiovasc Interv       Date:  2004-12       Impact factor: 2.692

8.  Treatment of isolated secundum atrial septal defects: impact of age and defect morphology in 1,013 consecutive patients.

Authors:  Gianfranco Butera; Enrico Romagnoli; Mario Carminati; Massimo Chessa; Luciane Piazza; Diana Negura; Alessandro Giamberti; Raul Abella; Giuseppe Pomè; Claudia Condoluci; Alessandro Frigiola
Journal:  Am Heart J       Date:  2008-07-30       Impact factor: 4.749

9.  Impact of occluder device type on success of percutaneous closure of atrial septal defects--a medium-term follow-up study.

Authors:  Michael Becker; Dorothee Frings; Jörg Schröder; Christina Ocklenburg; Eberhard Mühler; Rainer Hoffmann; Andreas Franke; Wolfgang Lepper
Journal:  J Interv Cardiol       Date:  2009-10-11       Impact factor: 2.279

10.  Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database.

Authors:  Daniel J DiBardino; Doff B McElhinney; Aditya K Kaza; John E Mayer
Journal:  J Thorac Cardiovasc Surg       Date:  2009-06       Impact factor: 5.209

View more
  9 in total

Review 1.  State-of-the-Art Atrial Septal Defect Closure Devices for Congenital Heart.

Authors:  Michael L O'Byrne; Daniel S Levi
Journal:  Interv Cardiol Clin       Date:  2019-01

2.  Cost comparison of transcatheter and operative closures of ostium secundum atrial septal defects.

Authors:  Michael L O'Byrne; Matthew J Gillespie; Russell T Shinohara; Yoav Dori; Jonathan J Rome; Andrew C Glatz
Journal:  Am Heart J       Date:  2015-02-21       Impact factor: 4.749

3.  Increasing propensity to pursue operative closure of atrial septal defects following changes in the instructions for use of the Amplatzer Septal Occluder device: An observational study using data from the Pediatric Health Information Systems database.

Authors:  Michael L O'Byrne; Russell T Shinohara; Elena K Grant; Joshua P Kanter; Matthew J Gillespie; Yoav Dori; Jonathan J Rome; Andrew C Glatz
Journal:  Am Heart J       Date:  2017-07-19       Impact factor: 4.749

4.  The influence of deficient retro-aortic rim on technical success and early adverse events following device closure of secundum atrial septal defects: An Analysis of the IMPACT Registry®.

Authors:  Michael L O'Byrne; Matthew J Gillespie; Kevin F Kennedy; Yoav Dori; Jonathan J Rome; Andrew C Glatz
Journal:  Catheter Cardiovasc Interv       Date:  2016-05-18       Impact factor: 2.692

Review 5.  Transcatheter device closure of atrial septal defects: more to think about than just closing the hole.

Authors:  Michael L O'Byrne; Andrew C Glatz; Matthew J Gillespie
Journal:  Curr Opin Cardiol       Date:  2018-01       Impact factor: 2.161

6.  Accuracy of Transthoracic Echocardiography in Assessing Retro-aortic Rim prior to Device Closure of Atrial Septal Defects.

Authors:  Michael L O'Byrne; Andrew C Glatz; David J Goldberg; Russell Shinohara; Yoav Dori; Jonathan J Rome; Matthew J Gillespie
Journal:  Congenit Heart Dis       Date:  2014-09-16       Impact factor: 2.007

7.  Should transcatheter closure of atrial septal defects with inferior-posterior deficient rim still be attempted?

Authors:  Pascal Amedro; Selin Bayburt; Anass Assaidi; Bernard Kreitmann; Gilbert Habib; Virginie Fouilloux; Alain Fraisse
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

8.  Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study.

Authors:  Daniel R Turner; Carl Y Owada; Charlie J Sang; Muhammad Khan; D Scott Lim
Journal:  Circ Cardiovasc Interv       Date:  2017-08       Impact factor: 6.546

9.  A novel three-dimensional echocardiographic method for device size selection in patients undergoing ASD trans-catheter closure.

Authors:  Alaa Roushdy; Aya El Sayegh; Yasmin Abdelrazek Ali; Hebattalla Attia; Azza El Fiky; Maiy El Sayed
Journal:  Egypt Heart J       Date:  2019-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.